OPEN END TURBO BULL - FRESENIUS MEDICAL CARE Stock

Certificat

DE000KJ171F6

Delayed Deutsche Boerse AG 05:59:30 2024-05-22 EDT
0.72 EUR -7.69% Intraday chart for OPEN END TURBO BULL - FRESENIUS MEDICAL CARE
Current month+11.43%
1 month+90.24%
Date Price Change
24-05-22 0.72 -7.69%
24-05-21 0.78 -9.30%
24-05-20 0.86 +1.18%
24-05-17 0.85 -3.41%
24-05-16 0.88 -3.30%

Delayed Quote Deutsche Boerse AG

Last update May 22, 2024 at 05:59 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Citi Citi
WKN KJ171F
ISINDE000KJ171F6
Date issued 2023-11-13
Strike 31.97
Maturity Unlimited
Parity 10 : 1
Emission price 0.07
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.93
Lowest since issue 0.11

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39.6 EUR
Average target price
39.84 EUR
Spread / Average Target
+0.61%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW